Table 4 Postoperative complications
From: Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures
Characteristic | Arista® AH (n = 103) | Control (n = 137) | p-value |
|---|---|---|---|
Ventilator dependence | 21(20.4%) | 33(24.1%) | NS |
Shock | 16(15.5%) | 21(15.3%) | NS |
Renal failure | 17(16.5%) | 23(16.8%) | NS |
Sepsis | 2(1.9%) | 2(1.5%) | NS |
Stroke | 5(4.9%) | 5(3.6%) | NS |
Unplanned re-exploration (<24 hrs) | 6(5.8%) | 9(6.6%) | NS |